Showing results (21-30 of 212) with videos related to
Sort By:
Pageof 22
Journal of Personalized Medicine|July 27, 2022
Allergic Asthma in the Era of Personalized MedicineNiki Papapostolou, Michael MakrisClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2020
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for AnticoagulationWolfgang Miesbach, Michael MakrisClinical Medicine (London, England)|August 4, 2018
The reversal of anticoagulation in clinical practice Sally Thomas, Michael MakrisFrontiers in Immunology|August 5, 2024
E-selectin in vascular pathophysiologyJinjin Zhang, Shengshi Huang, Zhiying Zhu, et al.Hamostaseologie|February 14, 2024
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant TreatmentScott Custo, Emma Tabone, Alexia Aquilina, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 2, 2010
Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodiesPratima Chowdary, Devaki Nair, Neil Davies, et al.Minerva Medica|April 9, 2021
Treatment of portal vein thrombosis: an updated narrative reviewLucia M Caiano, Nicoletta Riva, Marc Carrier, et al.Vascular Health and Risk Management|October 21, 2022
Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated ThrombosisLaura M Attard, Alex Gatt, Laurent Bertoletti, et al.Clinical Case Reports|June 8, 2017
Achieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab: two case reportsDonia Gamoudi, Melanie Cutajar, Nadia Gamoudi, et al.British Journal of Haematology|April 1, 2022
Efficacy and safety of the direct oral anti-coagulants in patients with cerebral vein thrombosis: A systematic review and meta-analysisNicoletta Riva, Francesca Galea, Isaac Buhagiar, et al.Pageof 22